Geron Corp. (GERN)
1.68
-0.01
(-0.59%)
USD |
NASDAQ |
Apr 17, 16:00
1.70
+0.02
(+1.19%)
After-Hours: 05:21
Geron SG&A Expense (Quarterly) : 41.67M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 130.00M |
| Recursion Pharmaceuticals, Inc. | 33.66M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Plus Therapeutics, Inc. | 4.168M |